Articles with public access mandates - Jean-Pierre JulienLearn more
Not available anywhere: 6
Axonal transport deficits and neurodegenerative diseases
S Millecamps, JP Julien
Nature Reviews Neuroscience 14 (3), 161-176, 2013
Mandates: Canadian Institutes of Health Research
Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS
F Gros‐Louis, G Soucy, R Larivière, JP Julien
Journal of neurochemistry 113 (5), 1188-1199, 2010
Mandates: Canadian Institutes of Health Research
Neuronal over‐expression of chromogranin A accelerates disease onset in a mouse model of ALS
SA Ezzi, R Larivière, M Urushitani, JP Julien
Journal of neurochemistry 115 (5), 1102-1111, 2010
Mandates: Fonds de recherche du Québec - Santé
Methylene blue administration fails to confer neuroprotection in two amyotrophic lateral sclerosis mouse models
JN Audet, G Soucy, JP Julien
Neuroscience 209, 136-143, 2012
Mandates: Canadian Institutes of Health Research
Gigaxonin mutation analysis in patients with NIFID
F Dequen, NJ Cairns, EH Bigio, JP Julien
Neurobiology of aging 32 (8), 1528-1529, 2011
Mandates: US National Institutes of Health
Potential Therapeutic Use of Withania somnifera for Treatment of Amyotrophic Lateral Sclerosis
K Dutta, V Swarup, JP Julien
Science of Ashwagandha: Preventive and Therapeutic Potentials, 389-415, 2017
Mandates: Canadian Institutes of Health Research, Natural Sciences and Engineering …
Available somewhere: 76
Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS
DA Bosco, G Morfini, NM Karabacak, Y Song, F Gros-Louis, P Pasinelli, ...
Nature neuroscience 13 (11), 1396-1403, 2010
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB–mediated pathogenic pathways
V Swarup, D Phaneuf, N Dupré, S Petri, M Strong, J Kriz, JP Julien
Journal of Experimental Medicine 208 (12), 2429-2447, 2011
Mandates: Canadian Institutes of Health Research
Extracellular mutant SOD1 induces microglial‐mediated motoneuron injury
W Zhao, DR Beers, JS Henkel, W Zhang, M Urushitani, JP Julien, ...
Glia 58 (2), 231-243, 2010
Mandates: US National Institutes of Health
Exosome secretion is a key pathway for clearance of pathological TDP-43
Y Iguchi, L Eid, M Parent, G Soucy, C Bareil, Y Riku, K Kawai, S Takagi, ...
Brain 139 (12), 3187-3201, 2016
Mandates: Canadian Institutes of Health Research, Natural Sciences and Engineering …
Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival
S Saxena, F Roselli, K Singh, K Leptien, JP Julien, F Gros-Louis, P Caroni
Neuron 80 (1), 80-96, 2013
Mandates: Canadian Institutes of Health Research
Requirement of myeloid cells for axon regeneration
B Barrette, MA Hébert, M Filali, K Lafortune, N Vallieres, G Gowing, ...
Journal of Neuroscience 28 (38), 9363-9376, 2008
Mandates: Canadian Institutes of Health Research
Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments
V Swarup, D Phaneuf, C Bareil, J Robertson, GA Rouleau, J Kriz, ...
Brain 134 (9), 2610-2626, 2011
Mandates: Canadian Institutes of Health Research
The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis
K Imamura, Y Izumi, A Watanabe, K Tsukita, K Woltjen, T Yamamoto, ...
Science Translational Medicine 9 (391), eaaf3962, 2017
Mandates: UK Medical Research Council, Parkinson's UK
Neurofilaments: neurobiological foundations for biomarker applications
AR Gafson, NR Barthélemy, P Bomont, RO Carare, HD Durham, JP Julien, ...
Brain 143 (7), 1975-1998, 2020
Mandates: US National Institutes of Health, National Institute of Health and Medical …
From animal models to human disease: a genetic approach for personalized medicine in ALS
V Picher-Martel, PN Valdmanis, PV Gould, JP Julien, N Dupré
Acta neuropathologica communications 4, 1-29, 2016
Mandates: Canadian Institutes of Health Research
Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase
G Gowing, T Philips, B Van Wijmeersch, JN Audet, M Dewil, ...
Journal of Neuroscience 28 (41), 10234-10244, 2008
Mandates: Research Foundation (Flanders), Canadian Institutes of Health Research
Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset
C Vande Velde, KK McDonald, Y Boukhedimi, M McAlonis-Downes, ...
PloS one 6 (7), e22031, 2011
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
CD11b+ Ly6G− myeloid cells mediate mechanical inflammatory pain hypersensitivity
N Ghasemlou, IM Chiu, JP Julien, CJ Woolf
Proceedings of the National Academy of Sciences 112 (49), E6808-E6817, 2015
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis
B Paré, M Lehmann, M Beaudin, U Nordström, S Saikali, JP Julien, ...
Scientific reports 8 (1), 14223, 2018
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Publication and funding information is determined automatically by a computer program